Inventor · disambiguated record
Richard B. Gaynor
Also filed as: GAYNOR RICHARD · GAYNOR RICHARD B · GAYNOR RICHARD BRIAN
8 granted patents·8 pending applications·225 citations·filing 1991–2022
89Inventor score
Top patents by PatentIndex Score
16 records- 0186US5597895ATransdominant tat mutants and uses thereofUNIV TEXAS·Filed 1992·Granted Jan 28, 1997·68 cites·11 claims
- 0279US5686264ACompositions and methods relating to transdominant Tat mutantsUNIV TEXAS·Filed 1994·Granted Nov 11, 1997·45 cites·21 claims
- 0369US5688511ACellular protein TDP-43 and regulation of HIV-1 gene expressionUNIV TEXAS·Filed 1994·Granted Nov 18, 1997·43 cites·20 claims
- 0468US5994108AMutant TAR virus and transdominant tat mutants as pharmacological agentsUNIV TEXAS·Filed 1994·Granted Nov 30, 1999·37 cites·12 claims
- 0557US2024366754A1Pharmaceutical compositions for delivery of viral antigens and related methodsBioNTech SE·Filed 2022·Application pending·0 cites
- 0653US5811233ACompositions and uses thereof in the diagnosis of psoriasisUNIV TEXAS·Filed 1994·Granted Sep 22, 1998·17 cites·32 claims
- 0751US2023083931A1Coronavirus vaccines and methods of useBIONTECH US INC·Filed 2021·Application pending·0 cites
- 0850US2022282217A1Compositions and methods for preparing t cell compositions and uses thereofBIONTECH US INC·Filed 2020·Application pending·0 cites
- 0948US2021386856A1Combination therapy with neoantigen vaccineBIONTECH US INC·Filed 2019·Application pending·0 cites
- 1048US2023141371A1Coronavirus vaccines and methods of useBIONTECH US INC·Filed 2021·Application pending·0 cites
- 1144US2019183972A1Combination of ramucirumab and pembrolizumab for the treatment of certain cancersIMCLONE LLC·Filed 2017·Application pending·0 cites
- 1243US2003032649A1Chimerizing protein kinases for drug discoveryFiled 2001·Application pending·0 cites
- 1342US5677143ACellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aidsREGENTS UNIVERSITY OF TX SYSTE·Filed 1994·Granted Oct 14, 1997·7 cites·31 claims
- 1441US2020062850A1Combination of an anti-vegfr-2 antibody and an anti-pd-l1 antibody for the treatment of cancerIMCLONE LLC·Filed 2017·Application pending·0 cites
- 1540US5350835ACellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aidsREGENTS UNIVERSITY OF TEXAS BO·Filed 1991·Granted Sep 27, 1994·6 cites·16 claims
- 1625US5534631ACellular factor ILFUNIV TEXAS·Filed 1992·Granted Jul 9, 1996·2 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Richard B. Gaynor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →